Evaluation of Diagnostic Yield of EUS-Guided Tissue Sampling
Multi-center Prospective Evaluation of the Diagnostic Yield of Endoscopic Ultrasound-Guided Tissue Sampling
1 other identifier
observational
54
1 country
1
Brief Summary
All patients will receive standard medical care and no experimental interventions will be performed. Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is a well-established procedure commonly used for the investigation of lesions within or adjacent to the gastrointestinal (GI) lumen (i.e. pancreas, liver, mediastinal masses, left adrenal gland, lymph nodes, and subepithelial lesions). EUS-guided tissue sampling has been commonly performed with different size and types of aspiration and core biopsy needles.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2016
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
November 29, 2016
CompletedFirst Posted
Study publicly available on registry
December 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2019
CompletedJanuary 6, 2020
January 1, 2020
3.2 years
November 29, 2016
January 2, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Overall diagnostic yield of EUS-TS
2 months
Secondary Outcomes (6)
Diagnostic Yield of EUS-guided tissue sampling solid lesions
2 months
Diagnostic Yield of EUS-guided tissue sampling cystic lesions
2 months
Diagnostic yield of EUS-TS using through-the-needle micro forceps
2 months
Diagnostic yield of EUS-TS using fine-needle aspiration
2 months
Diagnostic yield of EUS-TS using core biopsy needle
2 months
- +1 more secondary outcomes
Study Arms (1)
Endoscopic ultrasound- (EUS) guided tissue sampling
All patients scheduled to undergo EUS with tissue sampling (TS) as medically indicated will be considered for the study. Patients in whom EUS-TS is considered as part of their standard medical care will be offered to participate in this study.
Interventions
EUS- guided tissue sampling of solid and/or cystic pancreatic and non-pancreatic lesions as part of their medical care.
Eligibility Criteria
The study will include all patients who are scheduled to undergo EUS-guided tissue sampling as part of their standard of care.
You may qualify if:
- Age \>18 years old
- Patients referred for EUS-guided tissue sampling for lesions (i.e. pancreas, liver, mediastinal masses, left adrenal gland, lymph nodes, and subepithelial lesions).
- Target lesion should be ≥ 15 mm in size (long axis).
You may not qualify if:
- Any contraindication to performing endoscopy
- Unable to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Floridalead
- Borland Groover Clinic, Jacksonville, FLcollaborator
- Northwestern University, Chicago, ILcollaborator
- Mayo Cliniccollaborator
- Montefiore Medical Center, Bronx, NYcollaborator
- Columbia Universitycollaborator
- Johns Hopkins Universitycollaborator
- New York University, New York, NYcollaborator
- Yale Universitycollaborator
- Geisinger Medical Center, Danville, PAcollaborator
- Ochsner Health Systemcollaborator
Study Sites (1)
University of Florida
Gainesville, Florida, 32608, United States
Related Publications (1)
Yang D, Trindade AJ, Yachimski P, Benias P, Nieto J, Manvar A, Ho S, Esnakula A, Gamboa A, Sethi A, Gupte A, Khara HS, Diehl DL, El Chafic A, Shah J, Forsmark CE, Draganov PV. Histologic Analysis of Endoscopic Ultrasound-Guided Through the Needle Microforceps Biopsies Accurately Identifies Mucinous Pancreas Cysts. Clin Gastroenterol Hepatol. 2019 Jul;17(8):1587-1596. doi: 10.1016/j.cgh.2018.11.027. Epub 2018 Nov 22.
PMID: 30471456DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Dennis Yang, MD
University of Florida
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 29, 2016
First Posted
December 1, 2016
Study Start
June 1, 2016
Primary Completion
August 30, 2019
Study Completion
August 30, 2019
Last Updated
January 6, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will share
Computer-based files will only be made available to personnel involved in the study through the use of access privileges, passwords and encryption. The prospectively maintained database will be constructed with the Research Electronic Data Capture software.